IKBKE, a prognostic factor preferentially expressed in mesenchymal glioblastoma, modulates tumoral immunosuppression through the STAT3/PD‐L1 pathway

ABSTRACT:

SUBMITTER: Yi L 

PROVIDER: S-EPMC7418810 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature